InspireMD, Inc. — Director's Dealing 2026

Feb 2, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2026-01-15

Reporting Person: Gleason Shane Thomas (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-15	Common Stock	S	2909	$1.579	Disposed	1197462	Direct
2026-01-16	Common Stock	S	2250	$1.612	Disposed	1195212	Direct
2026-01-20	Common Stock	S	2955	$1.594	Disposed	1192257	Direct
2026-01-21	Common Stock	S	17593	$1.623	Disposed	1174664	Direct
2026-01-22	Common Stock	S	8411	$1.574	Disposed	1166253	Direct
2026-01-27	Common Stock	S	4781	$1.664	Disposed	1161472	Direct
2026-01-28	Common Stock	S	12395	$1.651	Disposed	1149077	Direct
2026-01-29	Common Stock	S	5000	$1.650	Disposed	1144077	Direct
2026-01-30	Common Stock	S	2900	$1.631	Disposed	1141177	Direct
2026-02-02	Common Stock	S	2000	$1.604	Disposed	1139177	Direct

Footnotes

F1: The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.